1. We possess powerful and efficient industrial capabilities, world‑leading fermentation capabilities, and substantial production scale.
2. Through an omni-channel, multi-model approach, we have established a marketing network covering major international markets.
Zhejiang Hisun Pharmaceutical Co., Ltd. (SSE: 600267), founded in 1956, is a state-owned comprehensive pharmaceutical and healthcare group. The company focuses on research & development, manufacturing, and marketing & sales of innovative drugs, biologics, generic medicine, and high-quality APIs, and at the same time, it also strategically expands into emerging sectors including animal health, holistic wellness, and medical aesthetics.
Employees
Invention Patents
R&D Talents
Localized management, rich product categories and sufficient production capacity
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
On March 10, the launch ceremony for Hisun’s R&D Center in Shanghai was successfully held at the Huichuang Valley Research Building of Fenglin International. Dr.
From bustling global cities to leading industry hubs, from core pharmaceutical exhibitions to health and wellness events, Hisun’s 2026 exhibition journey will span five continents,
On March 13, 2026, Zhejiang Hisun Pharmaceuticals Co., Ltd. (“Hisun”) and PiSA Farmacéutica (“PiSA”), Mexico’s largest pharmaceutical company, launched their strategic partnership through a cross-border
Share a few details about your needs, and we’ll connect you with the right specialist as soon as possible.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Join us at 2026 exhibitions and click to explore the full details
Founded in 1956, is a state-owned comprehensive pharmaceutical and healthcare group.
